TRIM17 and central nervous system cancer: Besides, extracting the data from CGGA, we performed methylation analyses, the outcomes showed that the methylation levels of TRIM17/21/22/24/28 in WHO IV gliomas were significantly lower than that in WHO II and WHO IV (P < 0.001) (Figure 9).